Humankind Investments LLC Sells 80 Shares of The Allstate Co. (NYSE:ALL)

Humankind Investments LLC decreased its holdings in The Allstate Co. (NYSE:ALL) by 4.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,654 shares of the insurance provider’s stock after selling 80 shares during the period. Humankind Investments LLC’s holdings in Allstate were worth $319,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. VSM Wealth Advisory LLC bought a new position in shares of Allstate in the 4th quarter worth $25,000. Twin Tree Management LP purchased a new position in Allstate in the fourth quarter valued at about $27,000. Vision Financial Markets LLC bought a new position in Allstate in the fourth quarter worth about $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of Allstate during the fourth quarter valued at about $29,000. Finally, Kapitalo Investimentos Ltda bought a new stake in shares of Allstate in the 4th quarter valued at about $29,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Trading Down 0.0 %

Shares of Allstate stock opened at $202.57 on Friday. The stock has a market cap of $53.64 billion, a PE ratio of 11.92, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32. The firm has a fifty day moving average price of $199.06 and a 200 day moving average price of $195.17. The Allstate Co. has a 1 year low of $156.66 and a 1 year high of $212.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts’ consensus estimates of $3.98 by ($0.45). Allstate had a net margin of 7.28% and a return on equity of 28.20%. The company had revenue of $14.30 billion for the quarter, compared to analysts’ expectations of $16.41 billion. During the same quarter in the previous year, the business posted $5.13 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Equities research analysts predict that The Allstate Co. will post 18.74 earnings per share for the current year.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 1.97%. The ex-dividend date of this dividend was Monday, March 10th. This is a positive change from Allstate’s previous quarterly dividend of $0.92. Allstate’s dividend payout ratio is currently 27.32%.

Allstate announced that its board has approved a share buyback plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ALL shares. Morgan Stanley increased their target price on shares of Allstate from $225.00 to $235.00 and gave the company an “overweight” rating in a research report on Tuesday, May 6th. Raymond James reiterated a “strong-buy” rating and set a $250.00 price objective (up previously from $240.00) on shares of Allstate in a report on Monday, May 5th. Wells Fargo & Company dropped their target price on Allstate from $200.00 to $197.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Evercore ISI increased their price target on Allstate from $227.00 to $230.00 and gave the company an “outperform” rating in a research note on Thursday, May 1st. Finally, JPMorgan Chase & Co. boosted their price target on Allstate from $217.00 to $222.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 8th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Allstate has a consensus rating of “Moderate Buy” and a consensus target price of $225.20.

Insider Transactions at Allstate

In related news, CFO Jesse E. Merten sold 40,102 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares of the company’s stock, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.